SUMMARY High concentrations of circulating immune complexes were detected by polyethylene glycol precipitation in 11 of 20 patients with myelofibrosis secondary to chronic myeloproliferative disease. Circulating immune complexes showed a positive correlation with plasma IgG concentrations both in patients and controls. Covariance analysis of the two groups showed significantly increased polyethylene glycol precipitable IgG in patients when adjusted for plasma IgG concentrations, indicating that the patients had significantly increased concentrations of complexed IgG. The immune complexes contained IgG, C3, and fibronectin and were inversely correlated with plasma fibronectin concentrations, suggesting that this major non-specific opsonin is important for the normal clearance of immune complexes. Therapeutic plasmapheresis efficiently removed circulating complexes and produced an increase in plasma fibronectin. This suggests that plasmapheresis may be useful for controlling immune complex mediated complications of these disorders.
Increased concentrations of circulating immune complexes have been shown in primary myelofibrosis by several different methods14 but their pathophysiological importance remains unclear.1 2 Plasma fibronectin is an opsonin which regulates macrophage phagocytosis of micro-organisms and perhaps immune complexes.5 As plasma fibronectin is reduced in some patients with chronic myeloproliferative disorders' we examined whether this is related to the high concentrations of circulating immune complexes. We also undertook a detailed study of the composition of immune complexes in these patients and examined the response to therapeutic plasmapheresis.
Patients and methods
Twenty patients with chronic myeloproliferative disorders and bone marrow fibrosis on trephine biopsy of the iliac crest were studied. There were five cases of primary myelofibrosis, 14 of polycythaemia vera, and one of essential thrombocythaemia. Sixteen healthy volunteers from the hospital staff served as control subjects.
Serum and plasma anticoagulated with edetic acid Two patients each underwent three therapeutic exchanges of plasma on alternate days on a Hemonetics 30 cell processor to determine the effect of removing immune complexes on plasma fibronectin concentrations. A total of4 litres of plasma from each patient was exchanged with 4 5% albumin (Blood Products Laboratory, Elstree, England). 
Results
The clinical features, haematological variables, and concentrations of immune complexes (polyethylene glycol IgG) in 20 patients are shown in table 1. Concentrations of immune complexes did not increase with age or duration of disease and were constant in stable patients on no treatment: 24 measurements made in seven patients over nine months showed a variation of 10 5 (7)% (mean + SD). Three patients with primary myelofibrosis, however, showed two to threefold increases in concentrations of immune complexes during the terminal phase of their disease.
Immune complex values did not correlate with spleen size or peripheral blood counts or with myelosuppressive chemotherapy over the preceding three months.
The normal range for plasma immune complex concentrations in 16 control subjects (mean + 2 SD) was 103 to 507 mg/l of polyethylene glycol precipitable IgG. Values higher than this were found in three of five patients with primary myelofibrosis, seven of 14 with polycythaemia rubra vera, and one with essential thrombocythaemia. Immune complexes and plasma IgG concentrations showed a significant positive correlation both in patients (r = 0 77, p < 0 001) and controls (r = 0-68, p < 0-01). Plasma IgG concentrations were 13-1 (4-1) g/l and 11-9 (2 5) g/l, respectively. Polyethylene glycol precipitable IgG expressed as a percentage of the plasma IgG concentration was, however, significantly greater in patients compared with that in normal subjects (4'3% v 2-6%, p < 0-001). Covariance analysis of controls and 1) . These results show that when a correction was made for plasma IgG concentrations, all the patients had significantly increased immune complex concentrations. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis of plasma polyethylene glycol precipitates showed up to nine protein bands. Table 2 compares the percentage of polyethylene glycol precipitation of the four opsonic proteins fibronectin IgG, C3, and IgM with the four non-opsonic proteins fibrinogen, a2 macroglobulin, haptoglobin, and albumin. The opsonic proteins all showed high polyethylene glycol precipitability compared with non-opsonic proteins, and up to 79% of patients' plasma fibronectin was polyethylene glycol precipitated in these experiments. Polyethylene glycol precipitable fibronectin, IgG, and C3 were significantly higher in patients than control subjects and precipitable IgG and C3 showed a significant positive correlation (r = 0-6, p < 0-005).
The precipitation of the opsonic proteins fibronectin, IgG, and C3 was significantly higher in plasma than in serum; 79% v 21% for fibronectin, Baglin, Simpson, Price, Boughton 4-3% v 16% for IgG, and 2-4% v 04% for C3 (p < 0.001).
When plasma fibronectin was purified by sepharose-gelatin affinity chromatography its polyethylene glycol precipitability fell from 70% to 1%. These results and the detection of multiple opsonic proteins in the polyethylene glycol precipitates from plasma suggest that fibronectin is polyethylene glycol precipitated because of the formation of complexes with other plasma proteins.
The normal mean (SD) range for edetic acid anticoagulated plasma fibronectin was 319-795 mg/l compared with a mean of 557 mg/l in controls; patients had significantly lower concentrations (mean 404 mg/I, p < 0-001). In patients plasma fibronectin concentrations showed a significant inverse correlation with those of immune complexes (r = -0-63, p < 0-001) (fig 2) .
The plasma fibronectin not precipitated by 2% polyethylene glycol may be viewed as free fibronectin not incorporated into immune complexes. This was significantly lower in patients with high concentrations of immune complexes (mean 42 mg/l) compared either with controls (mean 190 mg/l) or with patients with low concentrations of immune complexes (mean 137 mg/l, p < 0-001).
Plasmapheresis reduced circulating concentrations of immune complexes from 640 mg/l to 204 mg/l in one patient and from 584 mg/l to 159 mg/l in the second. Non-precipitable fibronectin concentrations rose from 21 to 157 mg/l and 68 to 123 mg/l, respectively (normal > 100 mg/l). Total fibronectin rose from 258 to 433 mg/l in the first patient and remained at 290 mg/l in the second.
Discussion
Immune complexes are activators of the platelet release reaction,'0 and the release of platelet derived growth factors by this mechanism may be an important stimulus to bone marrow fibroblasts in patients with myelofibrosis. group.bmj.com on April 13, 2017 -Published by http://jcp.bmj.com/ Downloaded from the fixed macrophage system may depend on effective opsonisation, and fibronectin is the major opsonin which regulates macrophage function.' In the presence of effective concentrations of opsonic fibronectin the clearance of immune complexes could prevent complex concentrations from rising, but if immune complex formation were to exceed fibronectin production, an accumulation of complexes might ensue. The negative correlation between immune complex concentrations and plasma fibronectin, and the restoration of total and non-precipitable plasma fibronectin concentrations following removal of immune complexes by plasmapheresis support this hypothesis. Plasma exchange was performed with 4.5% albumin which contains no fibronectin, and so the recovery of plasma fibronectin concentrations cannot be attributed to therapeutic replacement.
All patients were free from infection at the time of study and only one had biochemical evidence of liver dysfunction, but this patient did not have raised concentrations of immune complex, and plasma fibronectin was normal. Fibronectin depletion and high concentrations of immune complexes were therefore not a result of either infection or impaired liver function.
Using a fixed concentration of polyethylene glycol, protein precipitation by polyethylene glycol is proportionate to the protein concentration and to the molecular weight of the protein. 8 If, therefore, protein precipitation is expressed as a percentage of the initial protein concentration increased polyethylene glycol precipitation is determined by the molecular weight of the protein and its formation of high molecular weight complexes with other proteins.7 With 2% polyethylene glycol, we found that the percentage precipitation of non-opsonic proteins was minimal in both patients and controls. The increased precipitation of IgM was in keeping with its high molecular weight; the pronounced precipitation of the low molecular weight opsonic proteins fibronectin, IgG, and C3 was significantly higher in patients, and was most likely explained by the formation of high molecular weight complexes with other proteins.
The high precipitation of fibronectin in the presence of other plasma proteins compared with the isolated protein is also strong evidence in favour of complex formation. Fibronectin will form cryoprecipitable complexes with fibrinogen at -20°C but not in the 4°C to 22°C temperature range that we used. The minimal precipitation of fibrinogen and the much higher precipitation of fibronectin are strong evidence against this mechanism of polyethylene glycol precipitation of fibronectin. Furthermore, precipitation of fibronectin from serum that contained complexed IgG and C3 but no fibrinogen was also high.
As fibronectin is bound to fibrin during clot formation" the lower concentrations 
